Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countries

Clin Microbiol Infect. 2001 Dec;7(12):671-7. doi: 10.1046/j.1469-0691.2001.00344.x.

Abstract

Objective: To determine antimicrobial activity against Haemophilus influenzae and Moraxella catarrhalis.

Methods: A central laboratory performed NCCLS susceptibility testing for all isolates and beta-lactamase and capsular serotype determinations for H. influenzae.

Results: A total of 2712 H. influenzae and 1079 M. catarrhalis were collected. H. influenzae susceptibilities were >90% for amoxicillin/clavulanate, cefaclor, loracarbef, cefprozil, cefuroxime, ciprofloxacin, azithromycin and clarithromycin and were <80% for trimethoprim/sulfamethoxazole and ampicillin. 19.3% were beta-lactamase positive. The most common serotype was type-b (5.6%); 86.1% were nontypeable. M. catarrhalis had MIC90 within therapeutic range for all antimicrobials except ampicillin.

Conclusion: The conclusion of the study is that antimicrobials, except ampicillin and trimethoprim/sulfamethoxazole, remain good empiric choices against H. influenzae and M. catarrhalis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • Asia
  • Australia
  • Child
  • Child, Preschool
  • Egypt
  • Europe
  • Haemophilus influenzae / drug effects*
  • Haemophilus influenzae / isolation & purification
  • Humans
  • Infant
  • Mexico
  • Microbial Sensitivity Tests
  • Middle Aged
  • Moraxella catarrhalis / drug effects*
  • Moraxella catarrhalis / isolation & purification
  • beta-Lactamase Inhibitors

Substances

  • Anti-Bacterial Agents
  • beta-Lactamase Inhibitors